Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Front Endocrinol (Lausanne). 2022 Jul 11;13:882469. doi: 10.3389/fendo.2022.882469. eCollection 2022.
Diabetic wounds significantly affect the life quality of patients and may cause amputation and mortality if poorly managed. Recently, a wide range of cell-based methods has emerged as novel therapeutic methods in treating diabetic wounds. Adipose-derived stem cells (ASCs) are considered to have the potential for widespread clinical application of diabetic wounds treatment in the future. This review summarized the mechanisms of ASCs to promote diabetic wound healing, including the promotion of immunomodulation, neovascularization, and fibro synthesis. We also review the current progress and limitations of clinical studies using ASCs to intervene in diabetic wound healing. New methods of ASC delivery have been raised in recent years to provide a standardized and convenient use of ASCs.
糖尿病性伤口显著影响患者的生活质量,如果处理不当,可能导致截肢和死亡。最近,各种基于细胞的方法作为治疗糖尿病性伤口的新疗法出现。脂肪来源的干细胞 (ASCs) 被认为具有广泛的临床应用潜力,可用于治疗糖尿病性伤口。本综述总结了 ASCs 促进糖尿病伤口愈合的机制,包括促进免疫调节、新血管生成和纤维合成。我们还回顾了使用 ASCs 干预糖尿病伤口愈合的临床研究的最新进展和局限性。近年来,提出了 ASC 传递的新方法,以提供 ASC 的标准化和方便使用。